nicotine has been researched along with Nerve Degeneration in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (10.81) | 18.7374 |
| 1990's | 9 (24.32) | 18.2507 |
| 2000's | 18 (48.65) | 29.6817 |
| 2010's | 6 (16.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antilla, JC; Bickford, PC; Engberg, ME; Hudson, CE; Kang, CW; Lambert, CS; Philpot, RM; Rowell, PP; Wecker, L; Zesiewicz, TA | 1 |
| Florence, C; Guerreiro, S; Hamadat, S; Hirsch, EC; Michel, PP; Rousseau, E | 1 |
| Gao, Z; Legakis, L; Nissen, JC; Tsirka, SE | 1 |
| de la Monte, SM; Deochand, C; Silbermann, E; Tong, M; Yu, R; Zabala, V | 1 |
| Abreu-Villaça, Y; Cristina-Rodrigues, F; Filgueiras, CC; Manhães, AC; Oliveira-da-Silva, A; Vieira, FB | 1 |
| Maresova, D; Pokorny, J; Riljak, V | 1 |
| Ellsworth, K; Fan, W; Han, Y; Hu, J; Huang, Z; Hui, Y; Liu, Y; Wu, J; Zhu, C | 1 |
| Ellison, G | 1 |
| Hamaue, N; Sumikawa, K; Yamazaki, Y | 1 |
| Kulak, JM; Quik, M | 1 |
| Al Deeb, S; Al Moutaery, K; Elfaki, I; Khan, HA; Tariq, M | 1 |
| Langmeier, M; Riljak, V | 1 |
| Bao, S; Bordia, T; Di Monte, DA; Kim, A; Langston, JW; McCallum, SE; McCormack, A; Parameswaran, N; Quik, M; Tyndale, RF | 1 |
| Caldarone, BJ; Fitzsimonds, RM; Heintz, N; Ibanez-Tallon, I; King, SL; Lester, HA; Miwa, JM; Pavlides, C; Picciotto, MR; Stevens, TR; Xiao, C | 1 |
| Jandová, K; Langmeier, M; Milotová, M; Pokorný, J; Riljak, V | 1 |
| Abin-Carriquiry, JA; Costa, G; Dajas, F; Ferreira, M; Urbanavicius, J; Wonnacott, S | 1 |
| Akahoshi, N; Himi, T; Ishii, I; Ishizaki, Y; Murashima, YL | 1 |
| Akaike, A; Kimura, J; Shimohama, S; Tamura, Y; Yokota, T | 1 |
| Chalfie, M; Treinin, M | 1 |
| James, JR; Nordberg, A | 1 |
| Karan, L; Overstreet, DH; Rosecrans, JA | 1 |
| Desagher, S; Glowinski, J; Marin, P; Maus, M; Prémont, J | 1 |
| Boksa, P; Capek, R; Chaudieu, I; Clarke, PB; el-Bizri, H; Esplin, BA; Quik, M | 1 |
| Agnati, LF; Andbjer, B; Finnman, UB; Fuxe, K; Hasselrot, U; Lippoldt, A; Rosén, L | 1 |
| Brioni, JD; Morgan, SJ; O'Neill, AB | 1 |
| Adamson, KL; Chow, BL; Coen, KM; Corrigall, WA; Lança, AJ | 1 |
| Armstrong, B; Carlson, J; Ellison, G; Switzer, RC | 1 |
| Dumery, B; Hirsch, E; Marchand, V; Parain, K | 1 |
| Harris, BR; Hauser, KF; Holley, RC; Littleton, JM; Mayer, S; Prendergast, MA | 1 |
| Acosta, S; Miles, R; Strahlendorf, HK; Strahlendorf, JC | 1 |
| Carlson, J; Ellison, G; Noguchi, K | 1 |
| Ali, SF; Seidler, FJ; Slikker, W; Slotkin, TA; Xu, Z | 1 |
| Goiny, M; Herrera-Marschitz, M; Janson, AM; Meana, JJ | 1 |
| Agnati, LF; Andersson, K; Fuxe, K; Goldstein, M; Härfstrand, A; Janson, AM; Kitayama, I | 1 |
| Agnati, LF; Fuxe, K; Goldstein, M; Janson, AM; Sundström, E | 1 |
| Chiou, CY | 1 |
| Ceccarelli, B; Clementi, F; Mantegazza, P | 1 |
3 review(s) available for nicotine and Nerve Degeneration
| Article | Year |
|---|---|
Nicotine and nicotinic receptors; relevance to Parkinson's disease.
Topics: Animals; Basal Ganglia; Humans; Nerve Degeneration; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Parkinson Disease; Receptors, Nicotinic; RNA, Messenger; Substantia Nigra | 2002 |
Nicotine an efficient tool of the neurobiological research today, the tool of treatment tomorrow?
Topics: Animals; Antioxidants; Ganglionic Stimulants; Humans; Nerve Degeneration; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Parkinson Disease; Receptors, Cholinergic; Smoking | 2005 |
Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease.
Topics: Aging; Alzheimer Disease; Animals; Brain Chemistry; Drug Tolerance; Female; Humans; Male; Nerve Degeneration; Nicotine; Parkinson Disease; Receptors, Nicotinic; Sex Factors; Signal Transduction; Up-Regulation | 1995 |
34 other study(ies) available for nicotine and Nerve Degeneration
| Article | Year |
|---|---|
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
Topics: Animals; Ataxia; Benzazepines; Cerebellum; Dose-Response Relationship, Drug; Gait; Male; Mecamylamine; Motor Activity; Nerve Degeneration; Neural Pathways; Niacinamide; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Olivary Nucleus; Postural Balance; Pyridines; Quinoxalines; Rats; Rotarod Performance Test; Varenicline | 2013 |
The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in cooperation with nicotine.
Topics: Animals; Cells, Cultured; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Therapy, Combination; Intracellular Signaling Peptides and Proteins; Mesencephalon; Nerve Degeneration; Neuropeptides; Neuroprotective Agents; Nicotine; Orexins; Rats; Rats, Wistar; Sleep | 2015 |
Nicotine modulates neurogenesis in the central canal during experimental autoimmune encephalomyelitis.
Topics: Animals; Antigens; Autophagy-Related Proteins; Doublecortin Domain Proteins; Encephalomyelitis, Autoimmune, Experimental; Glial Fibrillary Acidic Protein; Inflammation; Intracellular Signaling Peptides and Proteins; Ki-67 Antigen; Leukocyte Common Antigens; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Myelin-Oligodendrocyte Glycoprotein; Nerve Degeneration; Nestin; Neural Stem Cells; Neurogenesis; Neuropeptides; Nicotine; Nicotinic Agonists; Peptide Fragments; Proteoglycans; Spinal Cord; Time Factors | 2015 |
Differential Contributions of Alcohol and Nicotine-Derived Nitrosamine Ketone (NNK) to White Matter Pathology in the Adolescent Rat Brain.
Topics: Animals; Drug Synergism; Ethanol; Forkhead Transcription Factors; Gene Expression; Growth Cones; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Male; Myelin-Associated Glycoprotein; Nerve Degeneration; Nerve Tissue Proteins; Nicotine; Nitrosamines; Oligodendroglia; Rats; Synapses; Transcription Factors; White Matter; Zebrafish Proteins | 2015 |
Increased apoptosis and reduced neuronal and glial densities in the hippocampus due to nicotine and ethanol exposure in adolescent mice.
Topics: Aging; Alcohol-Induced Disorders, Nervous System; Animals; Apoptosis; Cell Count; Central Nervous System Depressants; Disease Models, Animal; Drug Interactions; Ethanol; Female; Hippocampus; In Situ Nick-End Labeling; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroglia; Neurons; Nicotine; Nicotinic Agonists; Smoking | 2009 |
Nicotine effects on rat seizures susceptibility and hippocampal neuronal degeneration.
Topics: Animals; Cerebral Cortex; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Electrodes, Implanted; Electrophysiology; Evoked Potentials; Hippocampus; Injections, Intraperitoneal; Motor Cortex; Nerve Degeneration; Neurons; Nicotine; Nicotinic Agonists; Random Allocation; Rats; Rats, Wistar; Seizures | 2010 |
α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Animals, Newborn; Astrocytes; Bungarotoxins; Cells, Cultured; Disease Models, Animal; Dopaminergic Neurons; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Neuroprotective Agents; Nicotine; Receptors, Nicotinic | 2012 |
Neural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitry.
Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Cocaine; Habenula; Haplorhini; Humans; Medial Forebrain Bundle; Nerve Degeneration; Neuroanatomy; Nicotine; Perforant Pathway; Prosencephalon; Rats | 2002 |
Nicotine compensates for the loss of cholinergic function to enhance long-term potentiation induction.
Topics: Animals; Cholinergic Fibers; Long-Term Potentiation; Nerve Degeneration; Neural Inhibition; Nicotine; Nicotinic Agonists; Pyramidal Cells; Rats; Receptors, N-Methyl-D-Aspartate | 2002 |
Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Female; Glutathione; Huntington Disease; Injections, Subcutaneous; Motor Activity; Nerve Degeneration; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Receptors, Nicotinic; Tyrosine 3-Monooxygenase | 2005 |
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Biomarkers; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Administration Schedule; Female; Monoamine Oxidase; Nerve Degeneration; Neurons; Neurotoxins; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Saimiri; Substantia Nigra; Tyrosine 3-Monooxygenase | 2006 |
The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo.
Topics: Adaptor Proteins, Signal Transducing; Age Factors; Animals; Association Learning; Brain; Cell Survival; Excitatory Amino Acid Agonists; Membrane Glycoproteins; Membrane Potentials; Mice; Mice, Mutant Strains; Mutation; Nerve Degeneration; Neurons; Neuropeptides; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Receptors, Nicotinic | 2006 |
Morphological changes in the hippocampus following nicotine and kainic acid administration.
Topics: Animals; Benzimidazoles; Excitatory Amino Acid Agonists; Fluoresceins; Fluorescent Dyes; Hippocampus; Injections, Intraperitoneal; Kainic Acid; Male; NADPH Dehydrogenase; Nerve Degeneration; Neurons; Nicotine; Nicotinic Agonists; Organic Chemicals; Rats; Rats, Wistar; Staining and Labeling | 2007 |
Nicotine induces tyrosine hydroxylase plasticity in the neurodegenerating striatum.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Axons; Corpus Striatum; Denervation; Dopamine; Down-Regulation; Levodopa; Male; Nerve Degeneration; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2007 |
Increased expression of the lysosomal protease cathepsin S in hippocampal microglia following kainate-induced seizures.
Topics: Animals; Astrocytes; Cathepsins; Coloring Agents; Disease Models, Animal; Enzyme Activation; Epilepsy; Gene Expression Regulation, Enzymologic; Gliosis; Hippocampus; Kainic Acid; Lysosomes; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neurotoxins; Nicotine; Nicotinic Agonists; Oligonucleotide Array Sequence Analysis; Pyramidal Cells; Up-Regulation | 2007 |
Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cells, Cultured; Cerebral Cortex; Dizocilpine Maleate; Glutamates; Glutamic Acid; Nerve Degeneration; Neurons; Nicotine; Parasympathetic Nervous System; Parasympathomimetics; Piperazines; Rats; Receptors, N-Methyl-D-Aspartate | 1994 |
A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans.
Topics: Amino Acid Sequence; Animals; Base Sequence; Caenorhabditis; Gene Expression; Green Fluorescent Proteins; Luminescent Proteins; Macromolecular Substances; Molecular Sequence Data; Mutation; Nerve Degeneration; Nicotine; Phenotype; Receptors, Cholinergic; Recombinant Fusion Proteins; Restriction Mapping | 1995 |
Genetic, environmental, and situational factors mediating the effects of nicotine--an introduction.
Topics: Animals; Drug Tolerance; Female; Genetic Variation; Humans; Male; Nerve Degeneration; Nicotine; Personality; Rats; Rats, Sprague-Dawley; Sex Factors; Substance-Related Disorders | 1995 |
Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity.
Topics: Acetylcholine; Animals; Carbachol; Cells, Cultured; Dimethylphenylpiperazinium Iodide; Hexamethonium; Mice; N-Methylaspartate; Neostriatum; Nerve Degeneration; Nervous System Diseases; Neurons; Nicotine; Receptors, Cholinergic; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic | 1994 |
The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.
Topics: Amino Acids; Animals; Behavior, Animal; Brain Chemistry; Cells, Cultured; Chlorisondamine; Ganglia, Autonomic; Ganglionic Blockers; Hippocampus; In Vitro Techniques; Male; Nerve Degeneration; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Superior Cervical Ganglion; Synapses; Synaptic Transmission | 1994 |
Chronic continuous infusion of nicotine increases the disappearance of choline acetyltransferase immunoreactivity in the cholinergic cell bodies of the medial septal nucleus following a partial unilateral transection of the fimbria fornix.
Topics: Acetylcholinesterase; Animals; Choline O-Acetyltransferase; Hippocampus; Immunohistochemistry; Male; Nerve Degeneration; Neurons; Nicotine; Rats; Rats, Sprague-Dawley; Septal Nuclei | 1994 |
Histological and behavioral protection by (-)-nicotine against quinolinic acid-induced neurodegeneration in the hippocampus.
Topics: Animals; Brain Diseases; Cognition Disorders; Hippocampus; Male; Maze Learning; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Nicotine; Quinolinic Acid; Rats; Spatial Behavior | 1998 |
The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study.
Topics: Acetylcholine; Animals; Aziridines; Behavior, Animal; Choline; Cholinergic Fibers; Denervation; Dihydro-beta-Erythroidine; Excitatory Amino Acid Agonists; Ibotenic Acid; Male; Nerve Degeneration; Neuromuscular Blocking Agents; Neurons; Neurotoxins; Nicotine; Nicotinic Agonists; Pons; Rats; Rats, Long-Evans; Self Administration; Tegmentum Mesencephali; Tobacco Use Disorder | 2000 |
Selective neurotoxic effects of nicotine on axons in fasciculus retroflexus further support evidence that this a weak link in brain across multiple drugs of abuse.
Topics: Amphetamines; Animals; Axons; Central Nervous System Stimulants; Female; Limbic System; Mesencephalon; Nerve Degeneration; Neural Pathways; Neurotoxicity Syndromes; Neurotoxins; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Substance-Related Disorders | 2000 |
Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice.
Topics: Animals; Axons; Cotinine; Dopamine; Male; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Degeneration; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase | 2001 |
Chronic nicotine exposure reduces N-methyl-D-aspartate receptor-mediated damage in the hippocampus without altering calcium accumulation or extrusion: evidence of calbindin-D28K overexpression.
Topics: Animals; Autoradiography; Calbindin 1; Calbindins; Calcium; Calcium Radioisotopes; Cell Death; Dose-Response Relationship, Drug; Drug Administration Schedule; Hippocampus; Immunohistochemistry; N-Methylaspartate; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; S100 Calcium Binding Protein G | 2001 |
Choline blocks AMPA-induced dark cell degeneration of Purkinje neurons: potential role of the alpha7 nicotinic receptor.
Topics: Aconitine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; alpha7 Nicotinic Acetylcholine Receptor; Animals; Choline; Excitatory Amino Acid Agonists; Extracellular Space; Female; Gluconates; Insecticides; Lidocaine; Male; Meglumine; Nerve Degeneration; Neurotoxins; Nicotine; Nootropic Agents; Organ Culture Techniques; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Nicotinic; Sodium; Sodium Channels; Sodium Chloride; Tetrodotoxin | 2001 |
Nicotine produces selective degeneration in the medial habenula and fasciculus retroflexus.
Topics: Animals; Axons; Body Weight; Cotinine; Dose-Response Relationship, Drug; Efferent Pathways; Female; Habenula; Hyperkinesis; Nerve Degeneration; Neurotoxins; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Seizures; Silver Staining; Wallerian Degeneration | 2001 |
Fetal and adolescent nicotine administration: effects on CNS serotonergic systems.
Topics: Aging; Animals; Binding Sites; Brain; Carrier Proteins; Embryo, Mammalian; Female; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Degeneration; Nerve Tissue Proteins; Nicotine; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Presynaptic Terminals; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sex Characteristics; Synaptic Transmission; Tobacco Use Disorder | 2001 |
Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Corpus Striatum; Denervation; Depression, Chemical; Dialysis; Diencephalon; Dopamine; Extracellular Space; Homovanillic Acid; Male; Mesencephalon; Microchemistry; Nerve Degeneration; Nicotine; Rats; Rats, Inbred Strains | 1991 |
Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection.
Topics: Animals; Cell Count; Corpus Striatum; Dendrites; Dopamine; Functional Laterality; Male; Nerve Degeneration; Nerve Endings; Nicotine; Rats; Rats, Inbred Strains; Substantia Nigra; Tyrosine 3-Monooxygenase | 1988 |
Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nicotine; Pyridines; Receptors, Dopamine; Substantia Nigra | 1988 |
Effects of nicotine and acetylcholine on denervated chick biventer cervicis muscles.
Topics: Acetylcholine; Animals; Chickens; Cholinesterases; Drug Synergism; Muscle Contraction; Muscle Denervation; Muscles; Nerve Degeneration; Nicotine; Physostigmine | 1972 |
Adrenergic reinnervation of sommoth muscle of nictitating membrane by preganglionic sympathetic fibers.
Topics: Animals; Atropine; Autonomic Fibers, Preganglionic; Cats; Denervation; Electric Stimulation; Hexamethonium Compounds; Muscle Contraction; Muscle, Smooth; Nerve Degeneration; Neuromuscular Junction; Nicotine; Nictitating Membrane; Phentolamine | 1972 |